Inactivation with formaldehyde leads to non-toxic form of tetanus toxin.
Produced from tetanus toxin by inactivation with formaldehyde. The resulting toxoid is essentially non-toxic.
Shipping: Available products typically ship within 24/48h, via priority shipping.
Do you need support? Contact Customer Service or Technical Support.
Online Account
Access or Create Your Account
Product Details
Alternative Name |
Formaldehyde inactivated tetanus toxin |
---|---|
Concentration |
0.5μg/μl after reconstitution. |
Formulation |
Lyophilized. |
MW |
~150kDa |
Quality Control |
Immunoprecipitation; concentration determination by UV absorbance. |
Reconstitution |
Reconstitute with 200μl distilled water to get a 0.5μg/μl solution in 100mM histidine, 100mM sodium chloride and 5% trehalose, pH 7.0. |
UniProt ID |
P04958 |
Handling & Storage
Use/Stability |
As indicated on product label or CoA when stored as recommended. Stock solutions are stable for up to 6 months when stored at -20°C. |
---|---|
Handling |
Sealed under vacuum. Do not exceed one freeze/thaw cycle. Do not vortex. After reconstitution, prepare aliquots and store at -20°C. |
Long Term Storage |
+4°C |
Shipping |
Ambient Temperature |
Regulatory Status |
RUO – Research Use Only |
---|
- Lateral Flow-Based Skin Patch for Rapid Detection of Protein Biomarkers in Human Dermal Interstitial Fluid: E.C. Wilkirson, et al.; ACS Sens. , (2024), Abstract
- Development of a bead-based multiplex immunoassay for simultaneous quantitative detection of IgG serum antibodies against seven vaccine-preventable diseases: E.N. Bykonia, et al.; J. Immunol. Methods 512, 113408 (2023), Abstract
- Immunocompromised Patients with Therapy-Refractory Chronic Skin Diseases Show Reactivation of Latent Epstein-Barr Virus and Cytomegalovirus Infection: P. Speth, et al.; J. Invest. Dermatol. 142, 549 (2022), Abstract
- Structural basis of tetanus toxin neutralization by native human monoclonal antibodies: Wang, Y., Wu, C., et al.; Cell Rep. 35, 109070 (2021), Abstract
- Alloantigen-specific regulatory T cells generated with a chimeric antigen receptor: K.G. MacDonald, et al.; J. Clin. Invest. 126, 1413 (2016), Abstract — Full Text
- Tetanus vaccination with a dissolving microneedle patch confers protective immune responses in pregnancy: E. Esser, et al.; J. Control Release 236, 47 (2016), Application(s): ELISA for humoral immune responses, Abstract
- Molecular and functional characterization of allogantigen-specific anergic T cells suitable for cell therapy: R. Bacchetta, et al.; Haematologica 95, 2134 (2010), Abstract — Full Text
- Triggering the succinate receptor GPR91 on dendritic cells enhances immunity: T. Rubic, et al.; Nat. Immunol. 9, 1261 (2008), Abstract
Related Products

Purity | ≥99% |
---|---|
Source | From adenovirus type 40. Inactivated by 2 hours at 54°C. |

Source | From astrovirus type 1, strain A88/2 Newcastle. Inactivated by b-propiolactone 0.1% and 4 hours at 32°C. |
---|
C. difficile toxin A from ribotype 027, (native)
ENZ-PRT108
Highly purifed preparation from hypervirulent ribotype 027

Alternative Name | Clostridium difficile toxin A, tcdA, toxA |
---|---|
Purity | ≥95% (SDS-PAGE) |
Source | From Clostridium difficile, strain R20291 (Stoke Mandeville) ribotype 027. |
Last modified: May 29, 2024
Datasheet, Manuals, SDS & CofA
Manuals And Inserts
Certificate of Analysis
Please enter the lot number as featured on the product label
SDS
Enzo Life Science provides GHS Compliant SDS
If your language is not available please fill out the SDS request form